Advertisements



Clovis Oncology stock surges 50% on positive late-stage cancer trial results

Clovis Oncology Inc. shares surged 50% in premarket trade Monday after the company said its late-stage trial for a cancer drug met its primary endpoint and.....»»

Category: topSource: marketwatchJun 19th, 2017

Here"s Why Clovis Oncology (CLVS) Stock Skyrocketed Today

Shares of Clovis Oncology (CLVS) opened more than 40% higher on Monday morning after the company announced positive results in a late-stage trial involving its Rubraca therapy--an outcome that could help widen the use of the drug and.....»»

Category: topSource: zacksJun 19th, 2017

Novocure Ltd. Stock Surges Nearly 50% After Positive Late-stage Trial Results In Brain Cancer

Novocure Ltd. shares surged 49.4% in morning trade Monday after the company said its late-stage clinical trial in newly diagnosed glioblastoma showed positive results......»»

Category: topSource: foxnewsApr 3rd, 2017

Novocure Ltd. stock surges nearly 50% after positive late-stage trial results in brain cancer

Novocure Ltd. shares surged 49.4% in morning trade Monday after the company said its late-stage clinical trial in newly diagnosed glioblastoma showed positive results. Novocure found that the two-.....»»

Category: topSource: marketwatchApr 3rd, 2017

What’s Next For Clovis Oncology?

Clovis Oncology has delivered big results in a much-waited late-stage clinical trial for its ovarian cancer drug. Is a takeover on the horizon?.....»»

Category: blogSource: barronsJun 19th, 2017

Clovis Oncology Surges on Clutch Late-Stage Ovarian Cancer Trial

Clovis Oncology saw its shares make a massive gain early on Monday after the company announced top-line data from its confirmatory Phase 3 trial of its treatment of ovarian cancer......»»

Category: blogSource: 247wallstJun 19th, 2017

UPDATE: TG Therapeutics stock rises 4% on positive late-stage cancer trial results

TG Therapeutics Inc. shares rose 3.7% in morning trade Monday after the company said a late-stage clinical trial for its TG-1101 with AbbVi.....»»

Category: topSource: marketwatchJun 5th, 2017

TG Therapeutics stock rises 17% on positive late-stage cancer trial results

This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news......»»

Category: topSource: marketwatchJun 5th, 2017

Aerie Pharma stock surges 31% on positive late-stage trial results for glaucoma eye drops

This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news......»»

Category: topSource: marketwatchMay 24th, 2017

Aerie Pharma stock surges 32% on positive late-stage trial results for glaucoma eye drops

Aerie Pharmaceuticals Inc. shares surged as much as 32% in after hours trade Wednesday after the company said its eye drops intended for glaucoma had positive results in a late-stage clinical trial. If Aerie Pharma sees positive safe.....»»

Category: topSource: marketwatchMay 24th, 2017

Acorda stock surges 9% after positive late-stage clinical trial results for Parkinson"s drug

Acorda Therapeutics Inc. shares surged 9.0% in early morning trade after the company said its drug showed an imp.....»»

Category: topSource: marketwatchFeb 9th, 2017

Acorda stock surges 13% after positive late-stage clinical trial results for Parkinson"s drug

This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news......»»

Category: topSource: marketwatchFeb 9th, 2017

Bristol-Myers stock drops nearly 9% after Merck announces positive lung cancer drug results

Bristol-Myers Squibb shares dropped 8.7% in premarket trade on Monday after Merck & Co. announced positive mid/late-stage clinical trial results for its rival lung cancer drug over the weekend. Merck said its Keytruda, which treats advanced non-small-ce.....»»

Category: topSource: marketwatchOct 10th, 2016

Eli Lilly"s stock sinks after disappointing results from late-stage trial of cancer treatment

Shares of Eli Lilly & Co. sank 4.2% in premarket trade .....»»

Category: topSource: marketwatchOct 10th, 2017

UPDATE: Nabriva Therapeutics stock jumps 102% premarket on positive trial of pneumonia treatment

Nabriva Therapeutics plc shares surged 102% in premarket trade Monday, after the company reported positive results from a late-stage trial of a treatment for community-acquired bacterial pneumonia, or CAB.....»»

Category: topSource: marketwatchSep 18th, 2017

UPDATE: Nabriva Therapeutics stock jumps 82% premarket on positive trial of pneumonia treatment

Nabriva Therapeutics plc shares surged 82% in premarket trade Monday, after the company reported positive results from a late-stage trial of a treatment for community-acquired bacterial pneumonia, or CAB.....»»

Category: topSource: marketwatchSep 18th, 2017

Kura Oncology"s stock rockets after positive results from cancer treatment trial

Shares of Kura Oncology Inc. rocketed 26% in premarket trade F.....»»

Category: topSource: marketwatchSep 8th, 2017

Clovis Oncology"s stock soars 49% premarket after positive phase 3 trial results

This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news......»»

Category: topSource: marketwatchJun 19th, 2017

Acorda stock surges 10% on positive late-stage Parkinson"s results

Acorda Therapeutics Inc. shares surged 10.5% in heavy morning trade Tuesday after the company presented positive late-stage data for its Parkinson's disease drug. The company plans.....»»

Category: topSource: marketwatchJun 6th, 2017

Acorda Therapeutics stock surges 10% on positive late-stage Parkinson"s results

This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news......»»

Category: topSource: marketwatchJun 6th, 2017

UPDATE: Onconova Therapeutics stock surges 7% on positive mid-stage clinical trial results

Onconova Therapeutics Inc. stock surged 7% in morning trade Monday after the company said its drug had positive results in a mid-stage clinical trial for patients with higher-risk myelodysplastic syndromes, conditions that are considered a .....»»

Category: topSource: marketwatchJun 5th, 2017